Vidwan-ID : 164869



  • Dr Shaheen B Shaikh

  • Associate Professor
  • Yenepoya (Deemed to be University)
Publications 2013 - 2022

Publications

  • 26
    Journal Articles
  • 2
    Conference
    Proceedings
  • 1
    Review
  • 3
    Projects
  • 5

Google Scholar

Co-author Network


Expertise

Biochemistry and Molecular Biology

Medical Biochemistry and Endocrinology / Diabetology

Personal Information

Dr Shaheen B Shaikh

Female
Department of Biochemistry ,YMC Yenepoya University, Deralakatte
Mangaluru, Karnataka, India - 575018


Experience

  • Associate Professor

    Biochemistry (YMC)

    Yenepoya (Deemed to be University)


Qualification

  • MD

    JSS Medical College, Mysore


Honours and Awards

2018

• Post graduate Diploma in clinical endocrinology & Diabetes (RCP) UK 2017-2018

RCP (UK)

2017

• Distinction in DPPG from John Hopkeins University Of Medicine USA

USA

2010

First rank in MD Biochemistry, RGUHS Bangalore

RGUHS

2018

• Post graduate Diploma in clinical endocrinology & Diabetes (RCP) UK 2017-2018

RCP (UK)

2017

• Distinction in DPPG from John Hopkeins University Of Medicine USA

USA

2010

First rank in MD Biochemistry, RGUHS Bangalore

RGUHS

Read Less

Membership In Professional Bodies

2008

Member of Association of Medical Biochemists Karrnataka (AMBK)

Member

2008

Member of Association of Medical Biochemists Karrnataka (AMBK)

Member

Read Less

Membership In Committees

2021

COVID Task Force

Nodal Officer

2020

Board of Studies

MEMBER

2018

Anti Ragging Committee

MEMBER

2021

COVID Task Force

Nodal Officer

2020

Board of Studies

MEMBER

2018

Anti Ragging Committee

MEMBER

Read Less

Research Projects

Development and Evaluation of “YEN FIGHT DIABETES ’’ digital model for Comprehensive and Holistic Diabetes Care at Yenepoya Medical College Hospital for Prevention and Management of Diabetes Mellitus

Funding Agency : no

A Randomized , Double –blind ,Placibo-controlled ,Multicenter Study to Demonstrate the effects of Sotagliflozin on Cardiovascular and Renal Events in Type 2 Diabetes . The SCORED trial.

Funding Agency : Sanofi

A Comparative study of inflammatory markers and biochemical parameters among Diabetic and Non Diabetic patients with COVID – 19 and their influence on the disease outcome in tertiary care hospital of coastal Karnataka.

Funding Agency : self

Development and Evaluation of “YEN FIGHT DIABETES ’’ digital model for Comprehensive and Holistic Diabetes Care at Yenepoya Medical College Hospital for Prevention and Management of Diabetes Mellitus

Funding Agency : no

A Randomized , Double –blind ,Placibo-controlled ,Multicenter Study to Demonstrate the effects of Sotagliflozin on Cardiovascular and Renal Events in Type 2 Diabetes . The SCORED trial.

Funding Agency : Sanofi

A Comparative study of inflammatory markers and biochemical parameters among Diabetic and Non Diabetic patients with COVID – 19 and their influence on the disease outcome in tertiary care hospital of coastal Karnataka.

Funding Agency : self

Read Less